Diabetic retinopathy is a serious eye condition affecting individuals with diabetes, leading to vision impairment or blindness if untreated. Our treatment approach includes advanced therapies to preserve vision and enhance quality of life.
Key Treatments:
Regular eye exams and proactive management of blood sugar levels are crucial for early detection and prevention. Our comprehensive care strategy combines cutting-edge medical treatments with personalized patient education, ensuring optimal outcomes for those battling diabetic retinopathy. By integrating these advanced interventions, we aim to halt the progression of diabetic retinopathy, safeguard your vision, and improve your overall ocular health.
Diabetic retinopathy is a diabetes-related eye condition that affects the blood vessels in the retina and can lead to vision loss if not treated effectively. The treatment depends on the severity and progression of the disease.
Drugs such as Faricimab-svoa (Vabysmo), Ranibizumab (Lucentis), Aflibercept (Eylea), and Bevacizumab (Avastin) are injected into the eye to inhibit vascular endothelial growth factor (VEGF), which reduces abnormal blood vessel growth and leakage. Injections may be required monthly or as determined by the ophthalmologist.
This surgical procedure involves removing the vitreous gel and blood from leaking vessels, and sometimes scar tissue that might be causing retinal detachment. It is often used for severe cases, including those with significant bleeding (vitreous hemorrhage) or retinal detachment.
10/989 Soi Prasertmanukij 33 Nuanchan Buengkum District Bangkok 10230